200 related articles for article (PubMed ID: 36313690)
1. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
2. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
Front Oncol; 2022; 12():769203. PubMed ID: 35425708
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Schirmer CB; Renolen A; Borgen EF; Naume B; Wiedswang G
Ann Surg; 2020 Mar; 271(3):549-558. PubMed ID: 30216219
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study.
Li Z; Xu K; Tartarone A; Santarpia M; Zhu Y; Jiang G
Transl Lung Cancer Res; 2021 Feb; 10(2):995-1006. PubMed ID: 33718038
[TBL] [Abstract][Full Text] [Related]
8. Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer.
Chen X; Zhou F; Li X; Yang G; Zhao C; Li W; Wu F; Yu J; Gao G; Li J; Li A; Ren S; Zhou C
Ann Transl Med; 2020 May; 8(10):631. PubMed ID: 32566568
[TBL] [Abstract][Full Text] [Related]
9. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
[TBL] [Abstract][Full Text] [Related]
10. Preoperative CTC-Detection by CellSearch
Hugenschmidt H; Labori KJ; Borgen E; Brunborg C; Schirmer CB; Seeberg LT; Naume B; Wiedswang G
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513877
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
12. Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.
Dong X; Ma Y; Zhao X; Tian X; Sun Y; Yang Y; Zhao X
Ann Transl Med; 2020 Jun; 8(11):676. PubMed ID: 32617296
[TBL] [Abstract][Full Text] [Related]
13. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
Zhou C; Zhao R; Zhao R; Wang A; Li W
Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
[No Abstract] [Full Text] [Related]
15. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
Front Oncol; 2022; 12():912016. PubMed ID: 36203415
[TBL] [Abstract][Full Text] [Related]
16. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter
Jin L; Fan WH; Luan Y; Wu M; Zhao W
PeerJ; 2021; 9():e11366. PubMed ID: 33987029
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?
Sawabata N; Nakamura T; Kawaguchi T; Watanabe T; Ouji NS; Ito T; Taniguchi S
J Thorac Dis; 2020 Sep; 12(9):4623-4632. PubMed ID: 33145035
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
Bayarri-Lara C; Ortega FG; Cueto Ladrón de Guevara A; Puche JL; Ruiz Zafra J; de Miguel-Pérez D; Ramos AS; Giraldo-Ospina CF; Navajas Gómez JA; Delgado-Rodriguez M; Lorente JA; Serrano MJ
PLoS One; 2016; 11(2):e0148659. PubMed ID: 26913536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
